Search Results - Thomas Wirth

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Beyond FOXO1: AS1842856 inhibits GSK3 to enhance cytotoxic effects in B-ALL

    Beyond FOXO1: AS1842856 inhibits GSK3 to enhance cytotoxic effects in B-ALL by Franz Ketzer, Ulrike Büttner, Daniel Geist, Anita Kick, Thomas Wirth, Alexey Ushmorov

    Published 2025-07-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Characterization of Hospital Admissions During Immune Checkpoint Inhibitor Therapy: Insights From the ICOG Study

    Characterization of Hospital Admissions During Immune Checkpoint Inhibitor Therapy: Insights From the ICOG Study by Jonas Paul Wiegmann, Tabea Fröhlich, Nora Möhn, Laura Duzzi, Emily Narten, Johanna Aurich, Janin Thomas, Lea Grote‐Levi, Susann Mahjoub, Dominik Berliner, Thomas Wirth, Heiko Golpon, Benjamin‐Alexander Bollmann, Imke Von Wasilewski, Ralf Gutzmer, Florian H. Heidel, Thomas Skripuletz, Gernot Beutel, Philipp Ivanyi, ICOG‐CCCH (Immune Cooperative Oncology Group, Comprehensive Cancer Center Hannover)

    Published 2025-02-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: